Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following <i>in utero</i> opioid exposures in mouse fetuses.

Frontiers in toxicology·2024
Same author

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model.

Frontiers in pharmacology·2024
Same author

Rebuttal to the comments by Dr. Yan Xu on the article "Transcript profiling in the testes and prostates of postnatal day 30 Sprague-Dawley rats exposed prenatally and lactationally to 2-hydroxy-4-methoxybenzophenone".

Reproductive toxicology (Elmsford, N.Y.)·2019
Same author

Transcript profiling in the testes and prostates of postnatal day 30 Sprague-Dawley rats exposed prenatally and lactationally to 2-hydroxy-4-methoxybenzophenone.

Reproductive toxicology (Elmsford, N.Y.)·2018
Same author

Evaluation of Culture Time and Media in an In Vitro Testis Organ Culture System.

Birth defects research·2017
Same author

Evidence Favoring a Positive Feedback Loop for Physiologic Auto Upregulation of hnRNP-E1 during Prolonged Folate Deficiency in Human Placental Cells.

The Journal of nutrition·2017

Related Experiment Video

Updated: May 25, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Alternative models in developmental toxicology.

Hyung-yul Lee1, Amy L Inselman, Jyotshnabala Kanungo

  • 1Division of Personalized Nutrition and Medicine, FDA/National Center for Toxicological Research, Jefferson, AR 72079, USA.

Systems Biology in Reproductive Medicine
|January 14, 2012
PubMed
Summary

Toxicologists are exploring alternative methods for chemical safety testing due to regulatory pressures and high costs associated with animal use. This review examines whole embryo culture, mouse embryonic stem cell tests, and zebrafish as promising alternatives for developmental toxicity screening.

More Related Videos

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos
07:49

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos

Published on: August 25, 2019

Related Experiment Videos

Last Updated: May 25, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos
07:49

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos

Published on: August 25, 2019

Area of Science:

  • Toxicology
  • Developmental Biology
  • In Vitro Testing

Background:

  • Regulatory mandates like REACH necessitate extensive chemical safety testing, driving demand for alternatives to animal models.
  • Current animal testing for chemical safety, particularly for reproductive and developmental toxicity, is costly and involves millions of animals.
  • Pharmaceutical development faces high attrition rates and significant costs, partly due to animal testing requirements.

Purpose of the Study:

  • To review the current status of three alternative models for chemical safety testing: whole embryo culture (WEC), mouse embryonic stem cell test (mEST), and zebrafish.
  • To discuss the advantages and disadvantages of each alternative model.
  • To assess the potential of these models for future developmental toxicity screening.

Main Methods:

  • Review of existing literature on whole embryo culture (WEC) for developmental toxicity.
  • Review of existing literature on the mouse embryonic stem cell test (mEST) for developmental toxicity.
  • Review of existing literature on zebrafish as a model for developmental toxicity screening.

Main Results:

  • Whole embryo culture (WEC) offers a method to assess direct effects on early embryonic development.
  • The mouse embryonic stem cell test (mEST) provides a potential in vitro screening tool for teratogenicity.
  • Zebrafish present a vertebrate model amenable to high-throughput screening for developmental and reproductive toxicity.

Conclusions:

  • Whole embryo culture (WEC), mEST, and zebrafish are promising alternative models for chemical safety and developmental toxicity testing.
  • These alternative models offer potential to reduce reliance on animal testing, lower costs, and improve efficiency in chemical and pharmaceutical safety assessments.
  • Further research and validation are needed to fully integrate these alternative methods into regulatory safety testing strategies.